A New Guideline for Cervical Cancer Screening Physicians Lee Learman and Francisco Garcia discuss the updated U.S. Preventive Services Task Force guideline and the need to increase access to cervical cancer screening. by Anna Azvolinsky Forward Look Young Survivors at Risk for HPV-Related Cancers Study finds low vaccination rates among teen survivors. by Kate Yandell Cancer Control in the Community Successful public health initiatives to prevent, detect and treat cancer require widespread community participation. by Marci A. Landsmann Forward Look Little Consensus on Ovarian Cancer Monitoring Tests and scans may be overused. by Kate Yandell Survivor Profile Going Full Bore Susan Leighton, a 19-year survivor, is a powerful advocate for ovarian cancer research. Her advocacy, which began locally in northern Alabama, has reached the National Cancer Institute and the Department of Defense. by Sue Rochman Forward Look Cancer Centers Unite to Increase HPV Vaccination Rates Joint statement recommends girls and boys be vaccinated before age 13. by Cameron Walker Forward Look Uterine Cancer Rates on the Rise Study finds deaths are highest among African-American women. by Brenda Conaway Forward Look Identifying Ovarian Cancer Risk Study may help spotlight women who would benefit from risk reduction strategies. by Carrie Printz Yesterday & Today The Voice of Lamb Chop Ventriloquist Shari Lewis and her sidekick, a white wool puppet named Lamb Chop, won the hearts of generations of children who tuned in to her television shows. by Jocelyn Selim First Person Never Alone: A Family Journey A mother and daughter exchange thoughts about their “full-family experience” facing an ovarian cancer diagnosis and treatment. by Mary (Dicey) Jackson Scroggins and Nneka Scroggins next Cancer Talk Considering the Term “Cancer Survivor” A study investigates how people who have been diagnosed with cancer feel about being called survivors. by Jen Tota McGivney Making Clinical Trials More Inclusive Broadening clinical trial eligibility criteria to include cancer patients who also have other health conditions could increase trial enrollment. by Ashley P. Taylor What Do Clinical Trial Endpoints Really Measure? A study investigates whether a commonly used clinical trial endpoint, progression-free survival, can be used to predict quality of life. by Jon Kelvey Shingles Risk Increased for Cancer Patients A new vaccine is safe for cancer patients but hard to find. by Nancy Averett More Posts